Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

During the Trading Day
4.81 -0.07 / -1.43%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.82 +0.01 / +0.21%
 
Volume: 209.7K

Today’s Trading

Previous close4.88
Today’s open4.82
Day’s range4.51 - 4.86
Volume17,731,815
Average volume (3 months)7,186,359
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-17.45%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book5.08

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd-2.16-16.13%
RDUSRadius Health Inc-0.81-2.53%
HALOHalozyme Therapeutic...-0.37-4.47%
MCRBSeres Therapeutics I...-1.22-4.64%
Data as of 4:01pm ET, 02/05/2016

Financials

Next reporting dateMarch 28, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts

Partner Offers